{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:10:32Z","timestamp":1788844232151,"version":"build-2803163510"},"reference-count":22,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Introduction: Venous thromboembolism (VTE) remains a major complication following orthopedic trauma and fracture surgery. Low-molecular-weight heparin (LMWH) is widely used for prophylaxis; however, aspirin (ASA) has emerged as a potential alternative due to its ease of administration and cost-effectiveness. This study aimed to compare the efficacy and safety of aspirin (ASA) versus low-molecular-weight heparin (LMWH) in orthopedic trauma patients. Methods: A systematic review and meta-analysis was conducted by searching PubMed, Cochrane Library, and Google Scholar. Randomized controlled trials and comparative observational studies evaluating aspirin (ASA) versus low-molecular-weight heparin (LMWH) for venous thromboembolism (VTE) prophylaxis in orthopedic trauma patients were included. Outcomes assessed included overall venous thromboembolism (VTE), deep-vein thrombosis (DVT), pulmonary embolism (PE), fatal PE, mortality, bleeding complications, wound site infection, and hematoma formation. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Heterogeneity was assessed using the I(2) statistic. Results: Five studies comprising a heterogeneous orthopedic trauma population were included. No statistically significant difference between aspirin (ASA) and low-molecular-weight heparin (LMWH) in the incidence of venous thromboembolism (VTE) was noted (OR 0.52, 95% CI 0.02\u201312.25, p = 0.68). No significant differences were observed in the incidence of DVT between aspirin (ASA) and low-molecular-weight heparin (LMWH) (OR 1.00, 95% CI 0.46\u20132.16, p = 1.00). Pulmonary embolism (PE) (OR 0.96, 95% CI 0.72\u20131.28, p = 0.80), fatal PE (OR 0.55, 95% CI 0.18\u20131.65, p = 0.28), and mortality (OR 1.02, 95% CI 0.68\u20131.54, p = 0.91) were comparable between the two groups. Similarly, no significant differences were observed in bleeding complications (OR 0.95, 95% CI 0.86\u20131.05, p = 0.33) or wound complications (OR 1.05, 95% CI 0.81\u20131.37, p = 0.70). Hematoma formation showed a trend favoring aspirin (ASA) (OR 0.36, 95% CI 0.13\u20131.02, p = 0.05), although this did not reach statistical significance. Conclusions: Aspirin (ASA) may be a reasonable alternative to low-molecular-weight heparin (LMWH) for venous thromboembolism (VTE) prophylaxis in selected orthopedic trauma patients, with comparable outcomes for pulmonary embolism (PE), mortality, bleeding and wound complications. Larger high-quality randomized trials with standardized protocols in clearly defined orthopedic trauma populations are warranted to confirm these findings and guide clinical decision-making.<\/jats:p>","DOI":"10.3390\/jcm15176768","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:45:13Z","timestamp":1788241513000},"page":"6768","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aspirin vs. Low-Molecular-Weight Heparin in Orthopedic Trauma: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"15","author":[{"given":"Mohammed","family":"Alenezi","sequence":"first","affiliation":[{"name":"Department of General Surgery, Al-Adan Hospital, Kuwait City 52700, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4667-9402","authenticated-orcid":false,"given":"Abdulrahman O.","family":"Al-Naseem","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Al-Adan Hospital, Kuwait City 52700, Kuwait"},{"name":"Division of Orthopaedic Surgery, McGill University, Montreal, QC H3A 1B9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Alenezi","sequence":"additional","affiliation":[{"name":"Kuwait Institute of Medical Specialization, Kuwait City 13018, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Ali","sequence":"additional","affiliation":[{"name":"Faculty of Life Science and Medicine, King\u2019s College, London SE1 9RT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Almehandi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Science, University College London, London WC1E 6BT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8456-6209","authenticated-orcid":false,"given":"Anthony","family":"Albers","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Surgery, McGill University, Montreal, QC H3A 1B9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5872-0225","authenticated-orcid":false,"given":"Owayed","family":"Al Mutairi","sequence":"additional","affiliation":[{"name":"Ministry of Health, Kuwait City 13001, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-2488","authenticated-orcid":false,"given":"Ali","family":"Jarragh","sequence":"additional","affiliation":[{"name":"Department of Surgery, Health Sciences Centre, Faculty of Medicine, Kuwait University, Kuwait City 13001, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Haac, B.E., O\u2019Hara, N.N., Manson, T.T., Slobogean, G.P., Castillo, R.C., O\u2019Toole, R.V., Stein, D.M., and ADAPT Investigators (2020). Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0235628"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/BOT.0000000000003094","article-title":"Effect of Aspirin Versus Low-Molecular-Weight Heparin for Thromboprophylaxis in High-Risk and Fracture Location Subpopulations: A Secondary Analysis of the PREVENT CLOT Trial","volume":"40","author":"Tarpada","year":"2025","journal-title":"J. Orthop. Trauma"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"ehad655.2076","DOI":"10.1093\/eurheartj\/ehad655.2076","article-title":"Clinical effectiveness and safety of aspirin versus anticoagulation for venous thromboembolism prevention following orthopedic trauma and surgery: A meta-analysis of randomized controlled trials","volume":"44","author":"Dakay","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Haibier, A., Maimaitiniyazi, M., Lin, H., Liu, W., and Li, W. (2026). Aspirin vs. enoxaparin for thromboprophylaxis after total hip arthroplasty, total knee arthroplasty, or hip fracture surgery\u2014A systematic review and meta-analysis. Front. Med., 13.","DOI":"10.3389\/fmed.2026.1790739"},{"key":"ref_5","first-page":"100964","article-title":"Aspirin versus enoxaparin for venous thromboembolism (VTE) prophylaxis in orthopaedic trauma surgery: A systematic review","volume":"5","author":"Puga","year":"2026","journal-title":"J. Orthop. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Higgins, J.P.T., and Green, S. (2008). Cochrane Handbook for Systematic Reviews of Interventions, Wiley.","DOI":"10.1002\/9780470712184"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Major Extremity Trauma Research Consortium (METRC), O\u2019Toole, R.V., Stein, D.M., O\u2019Hara, N.N., Frey, K.P., Taylor, T.J., Scharfstein, D.O., Carlini, A.R., Sudini, K., and Degani, Y. (2023). Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture. N. Engl. J. Med., 388, 203\u2013213.","DOI":"10.1056\/NEJMoa2205973"},{"key":"ref_11","first-page":"83","article-title":"Does Aspirin Provide Adequate Chemoprophylaxis for Venous Thromboembolic Events in Operative Pelvic and Acetabular Fractures?","volume":"42","author":"Metcalf","year":"2022","journal-title":"Iowa Orthop. J."},{"key":"ref_12","first-page":"135","article-title":"Thromboprophylaxis after hip fracture: Evaluation of 3 pharmacologic agents","volume":"36","author":"Jeong","year":"2007","journal-title":"Am. J. Orthop."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s40267-018-0563-6","article-title":"Comparison between aspirin 325 mg and enoxaparin 40 mg as extended thromboprophylactic agents following major orthopedic surgery in Jordan University Hospital","volume":"35","author":"Alamiri","year":"2018","journal-title":"Drugs Ther. Perspect."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1345\/aph.1R331","article-title":"Aspirin for the Prophylaxis of Venous Thromboembolic Events in Orthopedic Surgery Patients: A Comparison of the AAOS and ACCP Guidelines with Review of the Evidence","volume":"47","author":"Stewart","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: Prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Riediger, C., Ferl, M., Sch\u00f6nrogge, M., and Halm-Pozniak, A. (2025). Oral Aspirin for Venous Thromboembolism Prophylaxis After Orthopedic Surgery: An Evidence-Based Review. Res. Sq.","DOI":"10.21203\/rs.3.rs-7764443\/v1"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13613-025-01587-0","article-title":"Hemostatic abnormalities after trauma resuscitation: Challenges and strategies in caring for the critically injured patient","volume":"15","author":"Reed","year":"2025","journal-title":"Ann. Intensive Care"},{"key":"ref_18","first-page":"e57","article-title":"Aspirin for Thromboprophylaxis after a Fracture","volume":"388","author":"Yoshino","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"The CRISTAL Study Group, Sidhu, V.S., Kelly, T., Pratt, N., Graves, S.E., Buchbinder, R., Adie, S., Cashman, K., Ackerman, I.N., and Bastiras, D. (2023). Effect of Aspirin vs Enoxaparin on 90-Day Mortality in Patients Undergoing Hip or Knee Arthroplasty. JAMA Netw. Open, 6, e2317838.","DOI":"10.1001\/jamanetworkopen.2023.17838"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zheng, X., Li, N., Song, Y., Han, L., Zhang, Y., Yin, Q., and Bian, Y. (2024). Comparison of efficacy and safety between aspirin and oral anticoagulants for venous thromboembolism prophylaxis after major orthopaedic surgery: A meta-analysis of randomized clinical trials. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1326224"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e933","DOI":"10.1097\/HS9.0000000000000933","article-title":"Aspirin as Thromboprophylaxis in Orthopedic Surgery: A Matter of Perspective","volume":"7","author":"Schutgens","year":"2023","journal-title":"HemaSphere"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1186\/s13018-024-05356-w","article-title":"Low-versus high-dose aspirin for venous thromboembolic prophylaxis after total joint arthroplasty: A systematic review and meta-analysis","volume":"19","author":"Mirghaderi","year":"2024","journal-title":"J. Orthop. Surg. Res."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6768\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:26:14Z","timestamp":1788841574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":22,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15176768"],"URL":"https:\/\/doi.org\/10.3390\/jcm15176768","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}